Margaret K. Vernon
Margaret provides scientific leadership regarding patient-reported outcome (PRO) instrument development and validation programs with a special interest in measurement in rare diseases. She has expertise in regulatory strategy and PRO clinical trial implementation and analysis, as well as significant expertise and formal training in both qualitative and quantitative methods. She has expertise in a wide range of therapeutic areas, including respiratory diseases, trauma and functional impairment, inflammatory diseases, neurology, pain, and oncology, among others.
Before joining Evidera, Margaret was a research psychologist at the Bureau of Labor Statistics’ Office of Survey Methods Research. During her tenure there, she worked primarily on measurement quality and survey development. Her duties included designing and implementing expert panels, focus groups, and cognitive interviews.
Margaret’s work has been published in numerous journals, including Quality of Life Research, Pharmacoeconomics, Journal of Asthma, Therapeutic Advances in Respiratory Disease, Sleep Medicine Reviews, Journal of Pain and Symptom Management and Schizophrenia Research. Additionally, Margaret is co-chair of an International Society for Pharmacoeconomics and Outcomes Research (ISPOR) task force on Patient and Observer-Reported Outcomes (PROs & OBSROs) Measurement in Rare Disease Clinical Trials – Emerging Good Practices. She has been responsible for validation and regulatory submission of two PROs that have achieved U.S. labeling claims in rare disease indications. She also serves as a member on Evidera’s outcomes research scientific leadership council.
Margaret received her PhD in developmental psychology with a minor concentration in statistics and methods from Pennsylvania State University, University Park.